文献速递乳腺癌放疗放疗物理与技术

大型州级质量联盟中左侧局限性乳腺癌大分割放疗后与心脏辐射剂量降低相关的因素

Factors Associated With Cardiac Radiation Dose Reduction After Hypofractionated Radiation Therapy for Localized, Left-Sided Breast Cancer in a Large Statewide Quality Consortium.
PubMed 文献 · Int J Radiat Oncol Biol Phys · 2023-10-03

分析密歇根放射肿瘤学质量联盟2016至2022年前瞻性收集的4165例左侧乳腺癌中等大分割放疗患者剂量学数据,心脏平均剂量目标从2016年≤2 Gy逐步收紧至2018年≤1.2 Gy、2021年≤1 Gy并增加PTV覆盖目标;总体心脏指标依从率91.7%,运动管理或俯卧位与达标相关,追加boost与不达标相关。

要点

  • 2016至2022年4165例左侧乳腺癌大分割放疗患者,总体心脏指标依从率91.7%。
  • 2016至2020年运动管理(OR 5.20)或俯卧位(OR 3.21)与达到MHD目标相关。
  • 2016至2020年追加boost(OR 0.25)与未达到MHD目标相关。

核心结论

  • 在该州级联盟中,限制心脏剂量的积极目标可获得高依从率,且未牺牲靶区覆盖。

研究设计与样本

  • 分析密歇根放射肿瘤学质量联盟2016至2022年前瞻性收集的左侧乳腺癌中等大分割放疗患者剂量学数据。
  • 共分析4165例患者,中位年龄64岁。
  • 心脏平均剂量目标从2016年≤2 Gy逐步收紧至2018年≤1.2 Gy,2021年增加PTV覆盖目标并将目标MHD降至≤1 Gy。
  • 采用多变量逻辑回归评估2016至2020年达到MHD目标及2021至2022年达到MHD/PTV联合目标的协变量。

主要发现

  • 总体平均心脏指标依从率为91.7%。
  • 运动管理使用率从2016至2020年的41.8%升至2021至2022年的46.5%。
  • 俯卧位使用率从2016至2020年的12.2%升至2021至2022年的22.2%。
  • 2016至2020年队列中,运动管理(OR 5.20;95%CI 3.59-7.54;P<.0001)或俯卧位(OR 3.21;95%CI 1.85-5.57;P<.0001)与达到MHD目标相关。
  • 2016至2020年队列中,追加boost(OR 0.25;95%CI 0.17-0.39;P<.0001)与未达到MHD目标相关。

关键数值与推荐

  • 2016年MHD目标≤2 Gy,2018年收紧至MHD≤1.2 Gy,2021年增加PTV覆盖目标并将目标MHD降至≤1 Gy。
  • 2016至2020年队列中,省略激素治疗(OR 0.65;95%CI 0.49-0.88;P=.0047)与未达到MHD目标相关。
  • 2021至2022年队列中,运动管理(OR 1.89;95%CI 1.12-3.21;P=.018)或俯卧位(OR 3.71;95%CI 1.73-7.95;P=.0008)与达到MHD/PTV联合目标相关。
  • 2021至2022年队列中,较大乳房体积(≥1440 cc;OR 0.34;95%CI 0.13-0.91;P=.031)与未达到MHD/PTV联合目标相关。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: Limiting cardiac radiation dose is important for minimizing long-term cardiac toxicity in patients with left-sided early-stage breast cancer. METHODS AND MATERIALS: Prospectively collected dosimetric data were analyzed for patients undergoing moderately hypofractionated radiation therapy to the left breast within the Michigan Radiation Oncology Quality Consortium from 2016 to 2022. The mean heart dose (MHD) goal was progressively tightened from ≤2 Gy in 2016 to MHD ≤ 1.2 Gy in 2018. In 2021, a planning target volume (PTV) coverage goal was added, and the goal MHD was reduced to ≤1 Gy. Multivariate logistic regression models were developed to assess for covariates associated with meeting the MHD goals in 2016 to 2020 and the combined MHD/PTV coverage goal in 2021 to 2022. RESULTS: In total, 4165 patients were analyzed with a median age of 64 years. Overall average cardiac metric compliance was 91.7%. Utilization of motion management increased from 41.8% in 2016 to 2020 to 46.5% in 2021 to 2022. Similarly, use of prone positioning increased from 12.2% to 22.2% in these periods. On multivariate analysis in the 2016 to 2020 cohort, treatment with motion management (odds ratio [OR], 5.20; 95% CI, 3.59-7.54; P < .0001) or prone positioning (OR, 3.21; 95% CI, 1.85-5.57; P < .0001) was associated with meeting the MHD goal, while receipt of boost (OR, 0.25; 95% CI, 0.17-0.39; P < .0001) and omission of hormone therapy (OR, 0.65; 95% CI, 0.49-0.88; P = .0047) were associated with not meeting the MHD goal. From 2021 to 2022, treatment with motion management (OR, 1.89; 95% CI, 1.12-3.21; P = .018) or prone positioning (OR, 3.71; 95% CI, 1.73-7.95; P = .0008) was associated with meeting the combined MHD/PTV goal, while larger breast volume (≥1440 cc; OR, 0.34; 95% CI, 0.13-0.91; P = .031) was associated with not meeting the combined goal. CONCLUSIONS: In our statewide consortium, high rates of compliance with aggressive targets for limiting cardiac dose were achievable without sacrificing target coverage.

来源:Int J Radiat Oncol Biol Phys,查看原文。版权归原作者所有。

引用

  1. Herr DJ, Moncion A, Griffith KA, et al. Factors Associated With Cardiac Radiation Dose Reduction After Hypofractionated Radiation Therapy for Localized, Left-Sided Breast Cancer in a Large Statewide Quality Consortium. Int J Radiat Oncol Biol Phys. 2023. PMID: 37797748. doi:10.1016/j.ijrobp.2023.09.013

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。